Paper1908442
Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.
Matthys P and 6 others. Int J Cancer, 1991. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Papers, record 1908442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1908442
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cachexia | Major topic |
| Interferon-gamma | Major topic |
| Neoplasms, Experimental | Major topic |
| Adipose Tissue | |
| Animals | |
| Anorexia | |
| Body Weight | |
| Cricetinae | |
| Cricetulus | |
| Feeding Behavior | |
| Mice | |
| Mice, Nude | |
| Survival Analysis |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42138129 | Pro-inflammatory cytokine-driven molecular signaling in skeletal muscle during cancer cachexia. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42138129 | PubMed |
| 41481467 | Metabolomic profiling reveals the potential of fatty acids as regulators of exhausted CD8 T cells during chronic viral infection. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41481467 | PubMed |
| 40655116 | Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice. | JCSM Commun | 2025 | https://conductscience.org/library/papers/40655116 | PubMed |
| 39812750 | Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/39812750 | PubMed |
| 39697630 | Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia. | Extracell Vesicles Circ Nucl Acids | 2024 | https://conductscience.org/library/papers/39697630 | PubMed |
| 38671295 | IL-6 promotes tumor growth through immune evasion but is dispensable for cachexia. | EMBO Rep | 2024 | https://conductscience.org/library/papers/38671295 | PubMed |
| 38482486 | Cancer-triggered systemic disease and therapeutic targets. | Holist Integr Oncol | 2024 | https://conductscience.org/library/papers/38482486 | PubMed |
| 38414161 | Cancer cachexia: biomarkers and the influence of age. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38414161 | PubMed |
| 38013040 | Growth differentiation factor-15 is an IFN-γ regulated mediator of infection-induced weight loss and the hepatic FGF21 response. | Brain Behav Immun | 2024 | https://conductscience.org/library/papers/38013040 | PubMed |
| 37116469 | Cachexia: A systemic consequence of progressive, unresolved disease. | Cell | 2023 | https://conductscience.org/library/papers/37116469 | PubMed |
| 36845136 | Anti-inflammatory actions of Pentosan polysulfate sodium in a mouse model of influenza virus A/PR8/34-induced pulmonary inflammation. | Front Immunol | 2023 | https://conductscience.org/library/papers/36845136 | PubMed |
| 36465353 | Review of the endocrine organ-like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36465353 | PubMed |
| 35646636 | Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia. | Front Oncol | 2022 | https://conductscience.org/library/papers/35646636 | PubMed |
| 35592439 | Development of a Therapeutic Peptide for Cachexia Suggests a Platform Approach for Drug-like Peptides. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/35592439 | PubMed |
| 35441960 | Pathological features of tissues and cell populations during cancer cachexia. | Cell Regen | 2022 | https://conductscience.org/library/papers/35441960 | PubMed |
| 35080147 | A systematic review examining the relationship between cytokines and cachexia in incurable cancer. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/35080147 | PubMed |
| 34899373 | Cancer-A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism. | Front Physiol | 2021 | https://conductscience.org/library/papers/34899373 | PubMed |
| 34608281 | The interplay of immunology and cachexia in infection and cancer. | Nat Rev Immunol | 2022 | https://conductscience.org/library/papers/34608281 | PubMed |
| 33329046 | Inflammation and Skeletal Muscle Wasting During Cachexia. | Front Physiol | 2020 | https://conductscience.org/library/papers/33329046 | PubMed |
| 33207208 | JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. | Cell Rep | 2020 | https://conductscience.org/library/papers/33207208 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1908442
GET https://conductscience.org/api/papers/v1/1908442/cited_by?page=2